Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by BioTeckon Jun 14, 2022 7:39pm
174 Views
Post# 34756693

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Used BioTech Company For Sale by Owner - 600M OBO.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Used BioTech Company For Sale by Owner - 600M OBO. Yes we did see this all coming. Everyone except the company. All this institution talk only makes sense if in fact institutions are aware of our existence. I question Sernovas ability to market. They have done a horrible job with retail so I don't see them doing a superb job with institutions. The proof is in the pudding and I don't see institutions or anyone pudding in any bids.
Redbaron2211 wrote: Agree MS especially with all the macro uncertainties.  The way management can protect the company from a cheap takeover would be a push for more institutional buying.  Unfortunately it doesn't come easy in this environment.  With the current sentiment and breadth extremes we are due for a multi month rebound in markets and given what DF points out with Sernova looking attractive at these valuations I agree and feel this will promote institutions to start accumulating when they are given the green light to do so.   


<< Previous
Bullboard Posts
Next >>